Scholar Monitor
This page is populated from _data/scholar.json. The GitHub Action can refresh totals and the latest citing papers on a schedule for Zhongqi Zhao's Google Scholar profile.
Recent citing papers
2026 · citing HQC-Bend: A Python Package of Hybrid Quantum-Classical Multi-cuts Benders' Decomposition Algorithm
DEB Neira
DEB Neira - arXiv preprint arXiv:2610.27362, 2026 - arxiv.org
2026 · citing HQC-Bend: A Python Package of Hybrid Quantum-Classical Multi-cuts Benders' Decomposition Algorithm
KM Lan
KM Lan - IEEE Access, 2026 - ieeexplore.ieee.org
2026 · citing A cancer nanovaccine based on an FeAl-layered double hydroxide framework for reactive oxygen species-augmented metalloimmunotherapy
Y Fan, J Zhang, Z Wang, Y Ren, Z Li, D Luo
Y Fan, J Zhang, Z Wang, Y Ren, Z Li, D Luo - Progress in Natural Science …, 2026 - Elsevier
2026 · citing A cancer nanovaccine based on an FeAl-layered double hydroxide framework for reactive oxygen species-augmented metalloimmunotherapy
L Chen, Y Sun, Y Dong, Y Jin, Z Han
L Chen, Y Sun, Y Dong, Y Jin, Z Han… - Journal of the …, 2026 - ACS Publications
2026 · citing A cancer nanovaccine based on an FeAl-layered double hydroxide framework for reactive oxygen species-augmented metalloimmunotherapy
L Ye, G Zhao, J Ma, Q Gan, N Luo, D Pan
L Ye, G Zhao, J Ma, Q Gan, N Luo, D Pan… - … and Targeted Therapy, 2026 - nature.com
2026 · citing A cancer nanovaccine based on an FeAl-layered double hydroxide framework for reactive oxygen species-augmented metalloimmunotherapy
Z Wang, J Cai, Y Wang, J Fan, J Lu, Y Ke
Z Wang, J Cai, Y Wang, J Fan, J Lu, Y Ke… - Chemical Engineering …, 2026 - Elsevier
2026 · citing A cancer nanovaccine based on an FeAl-layered double hydroxide framework for reactive oxygen species-augmented metalloimmunotherapy
V Ravichandran, R TM, S Balasubramanian
V Ravichandran, R TM, S Balasubramanian… - …, 2026 - Wiley Online Library
2026 · citing A cancer nanovaccine based on an FeAl-layered double hydroxide framework for reactive oxygen species-augmented metalloimmunotherapy
Y Zhu, W Sun, Y Huang, J Li, H Jiang
Y Zhu, W Sun, Y Huang, J Li, H Jiang… - International Journal …, 2026 - Taylor & Francis
2026 · citing A cancer nanovaccine based on an FeAl-layered double hydroxide framework for reactive oxygen species-augmented metalloimmunotherapy
LQ Zhao, CJ Bao, YN Liu, XF Liang, MQ Liu
LQ Zhao, CJ Bao, YN Liu, XF Liang, MQ Liu… - … Composites and Hybrid …, 2026 - Springer
2026 · citing A cancer nanovaccine based on an FeAl-layered double hydroxide framework for reactive oxygen species-augmented metalloimmunotherapy
J Wang, J Guo, T Cui, L Lin
J Wang, J Guo, T Cui, L Lin - ACS Nano Medicine, 2026 - ACS Publications